Zobrazeno 1 - 10
of 524
pro vyhledávání: '"Recombinant Human Thrombopoietin"'
Publikováno v:
ImmunoTargets and Therapy, Vol Volume 13, Pp 461-486 (2024)
Abdelrahman Elsayed,1 Basant Elsayed,1 Mohamed Elmarasi,1 Ahmed Adel Elsabagh,1 Engy Elsayed,2 Ibrahim Elmakaty,1 Mohamed Yassin2,3 1Department of Medical Education, Hamad Medical Corporation, Doha, Qatar; 2College of Medicine, Qatar University, Doha
Externí odkaz:
https://doaj.org/article/41f7025a57dd41de9462ec5a28de0481
Publikováno v:
Hematology, Vol 29, Iss 1 (2024)
Background: Cyclosporine A (CsA) and regular doses of recombinant human thrombopoietin (rhTPO) can accelerate platelet recovery in patients with non-severe aplastic anemia (NSAA). However, it is unclear whether CsA plus rhTPO at a higher dose can fur
Externí odkaz:
https://doaj.org/article/6bd4a9fb0f10477f9e6158fb3f98e340
Autor:
Jing Ni, Jian Hong, Xinglin Liang, Jifei Dai, Zhangbiao Long, ChengXin Luan, Mingzhen Yang, Qingsheng Li
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 8, Iss 7, Pp 102578- (2024)
Background: Thrombocytopenia after allogeneic hematopoietic cell transplantation is a challenging clinical problem. Recombinant human thrombopoietin (rhTPO) and thrombopoietin receptor agonists are increasingly used in posttransplant thrombocytopenia
Externí odkaz:
https://doaj.org/article/5087904f3c7b4959a969cd73617c7de9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jing Lin, Tong-Fei Wang, Mei-Juan Huang, Hao-Bo Huang, Pei-Fang Chen, Yu Zhou, Wei-Chao Dai, Ling Zhou, Xiu-Shan Feng, Hui-Lan Wang
Publikováno v:
BMC Pregnancy and Childbirth, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Background Treatment options for pregnant women with immune thrombocytopenia (ITP) who do not respond to first-line treatment are limited. Few studies have reported the use of recombinant human thrombopoietin (rhTPO) for this subset of patie
Externí odkaz:
https://doaj.org/article/69a8da92588b4003b9cbc7c5d2da5f11
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Objective: Based on real-world research, we aimed to evaluate the effectiveness and economy of recombinant human thrombopoietin (rhTPO) and recombinant human interleukin 11 (rhIL-11) in the treatment of cancer therapy induced thrombocytopenia (CTIT).
Externí odkaz:
https://doaj.org/article/a96602e727bc489987c33ee0abe38ce0
Autor:
Xiuli Wang, Hui Bi, Lin Liu, Yuebo Liu, Liefen Yin, Jin Yao, Jingxing Yu, Wei Tao, Yueping Wei, Yu Li, Lingmei Yin, Hongli Mu, Yadong Du, Zeping Zhou
Publikováno v:
Platelets, Vol 34, Iss 1 (2023)
AbstractThe conventional dose of recombinant human thrombopoietin (rhTPO) in the treatment of immune thrombocytopenia (ITP) is 300 U/kg per day, but the clinical reaction rate is not satisfactory. Accordingly, we explored the efficacy and safety of i
Externí odkaz:
https://doaj.org/article/f07a296c415546b3a6d4a0c23bf3e3be
Autor:
Xiaofan Liu, Yusheng Bai, Tao Wang, Yanping Song, Feng Sun, Ruixiang Xia, Feiyue Zhu, Jun Ma, Quanyi Lu, Xu Ye, Xinrong Zhan, Linjie Li, Xinhong Guo, Shuqin Cheng, Yan Li, Zhiqiang Guo, Youhua Chen, Shenxian Qian, Ling Qin, Qing Zhang, Sunqiong Cao, Renchi Yang
Publikováno v:
Platelets, Vol 34, Iss 1 (2023)
Recombinant human TPO (rhTPO) is effective for refractory/relapsed primary immune thrombocytopenia (ITP), but optimal dosing regimen remains elusive. In this multicenter, randomized, controlled trial, a total of 282 adult ITP patients (mean age 47.3
Externí odkaz:
https://doaj.org/article/289c4f91da7940189824cb7345fad1ef
Autor:
Jing-xin Zhou, Ling Gao, Nan Hu, Zhi-Ling Yan, Chun-ying Tian, Jing Su, Ji-Jin Qi, Jun-shuai Yue, Wen-tong Ma
Publikováno v:
Hematology, Vol 27, Iss 1, Pp 1062-1068 (2022)
Objective: Herein, we aimed to determine the clinical efficacy of recombinant human thrombopoietin (rhTPO) combined with glucocorticoids for treating immune thrombocytopenia (ITP).Methods: Clinical data of 87 patients with ITP admitted to our hospita
Externí odkaz:
https://doaj.org/article/5fcaf6518814418399dd20b8e8d7e72c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.